Proud to see our Íñigo González Larreategui presenting a flash talk and poster at #aseicacongress in Bilbao on the therapeutic impact and reactivation of tumor immunity by MYC inhibition in KRAS-driven NSCLC with diverse mutational landscapes. 👏 @aseica.bsky.social

Intense week for @LSoucekLab! We are happy to see our @dcapi14 presenting a poster on Targeting oncogene cooperation: MYC inhibition enhances response and overcomes resistance to KRAS inhibitors. #TargetingRAS2025 @TargetingRAS Targeting RAS symposium, Salamanca, 2025 👏💪

We are delighted to share that the review “MYC in cancer: from undruggable target to clinical trials” by Jonathan Whitfield and @lsoucek.bsky.social is finally out in Nature Review Drug Discovery. What an amazing journey this has been and still promises to be!
rdcu.be/eawOK

@lsoucek.bsky.social is presenting today a seminar at UB regarding the challenge associated to the development of a MYC inhibitor. Info below.